Science Explorer Interactive view Map
Company · Wellesley · United States

BioBridges (United States)

biobridges.comROR OpenAlex
Research works
16
▼ 62% vs 2013–17
Citations
271
17.2 per fractional work
Top-10% rate
4.7%
record average 16.5%
Open access
16%
world 28%

Not ranked overall: BioBridges (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 0.30× its world share, 0 worksBiochemistry, Geneti…Immunology and Microbiology: 3.30× its world share, 0 worksImmunology and Micro…Neuroscience: 6.83× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 31.46× its world share, 0 worksPharmacology, Toxico…Chemical Engineering: 31.71× its world share, 0 worksChemical EngineeringEngineering: 0.74× its world share, 0 worksEngineeringMedicine: 2.62× its world share, 2 worksMedicineBusiness, Management and Accounting: 0.13× its world share, 0 worksBusiness, Management…1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Chemical Engineering, 31.7×. Every wedge is a field page.

Which research topics does BioBridges (United States) publish most on?

By volume in 2022–2025: Lung Cancer Treatments and Mutations, Lung Cancer Research Studies, Neuroscience and Neural Engineering and Chemical Reactions and Isotopes.

Lung Cancer Treatments and Mutations: 0 fractional worksLung Cancer Research Studies: 0 fractional worksNeuroscience and Neural …0Neuroscience and Neural Engineering: 0 fractional worksChemical Reactions and I…0Chemical Reactions and Isotopes: 0 fractional worksAnalytical Chemistry and…0Analytical Chemistry and Sensors: 0 fractional worksCCD and CMOS Imaging Sen…0CCD and CMOS Imaging Sensors: 0 fractional worksAdvanced Breast Cancer Therapies: 0 fractional worksHER2/EGFR in Cancer Research: 0 fractional worksChronic Lymphocytic Leukemia Research: 0 fractional worksGalectins and Cancer Biology: 0 fractional works
Pulmonary and Respiratory MedicineOncologyCellular and Molecular NeurosciencePharmaceutical Science4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 0 works
  2. 2 Lung Cancer Research Studies Oncology 0 works
  3. 3 Neuroscience and Neural Engineering Cellular and Molecular Neuroscience 0 works
  4. 4 Chemical Reactions and Isotopes Pharmaceutical Science 0 works
  5. 5 Analytical Chemistry and Sensors Bioengineering 0 works
  6. 6 CCD and CMOS Imaging Sensors Electrical and Electronic Engineering 0 works
  7. 7 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 0 works
  8. 8 HER2/EGFR in Cancer Research Oncology 0 works
  9. 9 Chronic Lymphocytic Leukemia Research Genetics 0 works
  10. 10 Galectins and Cancer Biology Immunology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available16.4%not open83.6%

World: 28% of research is openly available.

with international co-authors17.7%domestic only82.3%

World: 19% is written across borders.

How has BioBridges (United States)'s research output changed?

Output in 2018–2022 was 62% lower than in 2013–2017.

201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Wellesley

All research institutions in Wellesley

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.